FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968373669> ?p ?o ?g. }

• W1968373669 endingPage "463" @default.
• W1968373669 startingPage "458" @default.
• W1968373669 abstract "No AccessJournal of UrologyAdult Urology1 Aug 2014Overactive Bladder Changes with Time: A 5-Year Longitudinal Followup of Changes in Overactive Bladder Symptoms, Urodynamic Studies and Urinary Nerve Growth Factor Levels Fei-Chi Chuang, Hsin-Tzu Liu, Li-Yu Wang, and Hann-Chorng Kuo Fei-Chi ChuangFei-Chi Chuang Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, Republic of China More articles by this author , Hsin-Tzu LiuHsin-Tzu Liu Department of Urology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan, Republic of China Institute of Pharmacology and Toxicology, Tzu Chi University, Hualien, Taiwan, Republic of China More articles by this author , Li-Yu WangLi-Yu Wang Department of Medicine, Mackay Medical College, New Taipei City, Taiwan, Republic of China More articles by this author , and Hann-Chorng KuoHann-Chorng Kuo Department of Urology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan, Republic of China Department of Urology, Tzu Chi University, Hualien, Taiwan, Republic of China More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.091AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We compared clinical symptoms, urodynamic diagnoses and urinary nerve growth factor levels at baseline and 5 years later in patients with overactive bladder. Materials and Methods: Patients diagnosed with overactive bladder at a tertiary teaching hospital who underwent urinary nerve growth factor tests 5 years previously were identified by chart review. Patients were invited to return for symptom evaluation, urodynamic studies and a repeat urinary nerve growth factor test. Changes in overactive bladder subtype, urgency severity score and urodynamic diagnosis were classified as improved, stable or worse. Changes in urinary nerve growth factor/creatinine were compared between baseline and 5 years later according to changes in bladder conditions. Results: A total of 30 women and 45 men completed the study. Mean ± SD age was 73.5 ± 10.3 years. Urinary nerve growth factor/creatinine showed no significant difference among patients with improved, stable or worse bladder conditions based on overactive bladder or urgency severity score subtypes. However, urinary nerve growth factor/creatinine was significantly decreased in patients with an improved urodynamic diagnosis (mean 0.94 ± 1.36 vs 0.17 ± 0.19 pg/mg, p = 0.02), significantly increased in patients with a worse urodynamic diagnosis (0.55 ± 0.85 vs 2.08 ± 2.81 pg/mg, p = 0.04) and showed no change in those with a stable urodynamic diagnosis. Multiple linear regression analysis revealed that the change in urodynamic diagnosis was still predictive of the change in urinary nerve growth factor/creatinine after adjusting for age, gender, overactive bladder and urgency severity score subtypes (p = 0.001). Conclusions: Urinary nerve growth factor/creatinine did not reflect the changes in bladder conditions based on subjective symptoms. However, the levels reflected dynamic changes in bladder pathophysiology according to urodynamic findings. References 1 : Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndrome. World J Urol2012; 30: 385. Google Scholar 2 : Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol2002; 4: S7. Google Scholar 3 : Defining overactive bladder as hypersensitivity. Neurourol Urodyn2007; 26: 904. Google Scholar 4 : An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn2010; 29: 4. Google Scholar 5 : Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J Urol2008; 179: 2270. Link, Google Scholar 6 : Urinary nerve growth factor in women with overactive bladder syndrome. BJU Int2011; 107: 799. Google Scholar 7 : Urinary nerve growth factor: a biomarker of detrusor overactivity? A systematic review. Int Urogynecol J2013; 24: 1603. Google Scholar 8 : Validity and reliability of the patient's perception of intensity of urgency scale in overactive bladder. BJU Int2011; 107: 1612. Google Scholar 9 : Strong correlation between the overactive bladder symptom score and urgency severity score in assessment of patients with overactive bladder syndrome. Tzu Chi Med J2010; 22: 82. Google Scholar 10 : Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol2000; 161: 273. Google Scholar 11 : The natural history of lower urinary tract symptoms in females: analysis of a health screening project. Eur Urol2007; 52: 1744. Google Scholar 12 : The natural history of the overactive bladder syndrome in females: a long-term analysis of a health screening project. Neurourol Urodyn2011; 30: 1437. Google Scholar 13 : Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review. Eur Urol2010; 58: 532. Google Scholar 14 : A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Eur Urol2009; 55: 783. Google Scholar 15 : Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years. Eur Urol2010; 58: 149. Google Scholar 16 : The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Urology2003; 61: 37. Google Scholar 17 : The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects. BJU Int2005; 95: 335. Google Scholar 18 : Is the bladder a reliable witness for predicting detrusor overactivity?. J Urol2006; 175: 191. Link, Google Scholar 19 : Overactive bladder symptoms: do we need urodynamics?. Neurourol Urodyn2003; 22: 105. Google Scholar 20 : Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome. Neurourol Urodyn2011; 30: 1300. Google Scholar 21 : The long-term natural history of overactive bladder symptoms due to idiopathic detrusor overactivity in women. BJU Int2009; 104: 948. Google Scholar 22 : A long-term study of the persistence of the urodynamic characteristics of the unstable bladder. Br J Urol1981; 53: 310. Google Scholar 23 : Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int2009; 103: 1668. Google Scholar 24 : Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol2009; 56: 700. Google Scholar 25 : Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol2008; 53: 1245. Google Scholar 26 : The concept of neurogenic inflammation. BJU Int2008; 101: 2. Google Scholar 27 : Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention. Neurourol Urodyn2009; 28: 78. Google Scholar © 2014 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byKuo H (2018) Editorial CommentJournal of Urology, VOL. 197, NO. 6, (1494-1495), Online publication date: 1-Jun-2017. Volume 192Issue 2August 2014Page: 458-463 Advertisement Copyright & Permissions© 2014 by American Urological Association Education and Research, Inc.Keywordsnerve growth factorcreatinineurinary bladdermuscle hypertoniaurodynamicsoveractiveMetricsAuthor Information Fei-Chi Chuang Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, Republic of China More articles by this author Hsin-Tzu Liu Department of Urology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan, Republic of China Institute of Pharmacology and Toxicology, Tzu Chi University, Hualien, Taiwan, Republic of China More articles by this author Li-Yu Wang Department of Medicine, Mackay Medical College, New Taipei City, Taiwan, Republic of China More articles by this author Hann-Chorng Kuo Department of Urology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan, Republic of China Department of Urology, Tzu Chi University, Hualien, Taiwan, Republic of China More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W1968373669 created "2016-06-24" @default.
• W1968373669 creator A5053694613 @default.
• W1968373669 creator A5064972271 @default.
• W1968373669 creator A5072499855 @default.
• W1968373669 creator A5087741922 @default.
• W1968373669 date "2014-08-01" @default.
• W1968373669 modified "2023-10-03" @default.
• W1968373669 title "Overactive Bladder Changes with Time: A 5-Year Longitudinal Followup of Changes in Overactive Bladder Symptoms, Urodynamic Studies and Urinary Nerve Growth Factor Levels" @default.
• W1968373669 cites W1507591711 @default.
• W1968373669 cites W1877069654 @default.
• W1968373669 cites W1965675462 @default.
• W1968373669 cites W1967198861 @default.
• W1968373669 cites W1968860914 @default.
• W1968373669 cites W1977422473 @default.
• W1968373669 cites W1996242258 @default.
• W1968373669 cites W2003049224 @default.
• W1968373669 cites W2008311876 @default.
• W1968373669 cites W2031978047 @default.
• W1968373669 cites W2032145079 @default.
• W1968373669 cites W2033189766 @default.
• W1968373669 cites W2037706235 @default.
• W1968373669 cites W2038741210 @default.
• W1968373669 cites W2039288810 @default.
• W1968373669 cites W2046804170 @default.
• W1968373669 cites W2061312008 @default.
• W1968373669 cites W2068146214 @default.
• W1968373669 cites W2070162219 @default.
• W1968373669 cites W2073620026 @default.
• W1968373669 cites W2083589599 @default.
• W1968373669 cites W2119707592 @default.
• W1968373669 cites W2134032760 @default.
• W1968373669 cites W2136591657 @default.
• W1968373669 doi "https://doi.org/10.1016/j.juro.2014.02.091" @default.
• W1968373669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24594404" @default.
• W1968373669 hasPublicationYear "2014" @default.
• W1968373669 type Work @default.
• W1968373669 sameAs 1968373669 @default.
• W1968373669 citedByCount "14" @default.
• W1968373669 countsByYear W19683736692015 @default.
• W1968373669 countsByYear W19683736692016 @default.
• W1968373669 countsByYear W19683736692017 @default.
• W1968373669 countsByYear W19683736692018 @default.
• W1968373669 countsByYear W19683736692019 @default.
• W1968373669 countsByYear W19683736692021 @default.
• W1968373669 countsByYear W19683736692023 @default.
• W1968373669 crossrefType "journal-article" @default.
• W1968373669 hasAuthorship W1968373669A5053694613 @default.
• W1968373669 hasAuthorship W1968373669A5064972271 @default.
• W1968373669 hasAuthorship W1968373669A5072499855 @default.
• W1968373669 hasAuthorship W1968373669A5087741922 @default.
• W1968373669 hasConcept C126322002 @default.
• W1968373669 hasConcept C126894567 @default.
• W1968373669 hasConcept C142724271 @default.
• W1968373669 hasConcept C170493617 @default.
• W1968373669 hasConcept C204787440 @default.
• W1968373669 hasConcept C2778423431 @default.
• W1968373669 hasConcept C2778531004 @default.
• W1968373669 hasConcept C2778941218 @default.
• W1968373669 hasConcept C2779762690 @default.
• W1968373669 hasConcept C2911213092 @default.
• W1968373669 hasConcept C71924100 @default.
• W1968373669 hasConcept C77411442 @default.
• W1968373669 hasConceptScore W1968373669C126322002 @default.
• W1968373669 hasConceptScore W1968373669C126894567 @default.
• W1968373669 hasConceptScore W1968373669C142724271 @default.
• W1968373669 hasConceptScore W1968373669C170493617 @default.
• W1968373669 hasConceptScore W1968373669C204787440 @default.
• W1968373669 hasConceptScore W1968373669C2778423431 @default.
• W1968373669 hasConceptScore W1968373669C2778531004 @default.
• W1968373669 hasConceptScore W1968373669C2778941218 @default.
• W1968373669 hasConceptScore W1968373669C2779762690 @default.
• W1968373669 hasConceptScore W1968373669C2911213092 @default.
• W1968373669 hasConceptScore W1968373669C71924100 @default.
• W1968373669 hasConceptScore W1968373669C77411442 @default.
• W1968373669 hasIssue "2" @default.
• W1968373669 hasLocation W19683736691 @default.
• W1968373669 hasLocation W19683736692 @default.
• W1968373669 hasOpenAccess W1968373669 @default.
• W1968373669 hasPrimaryLocation W19683736691 @default.
• W1968373669 hasRelatedWork W183249409 @default.
• W1968373669 hasRelatedWork W1977422473 @default.
• W1968373669 hasRelatedWork W1982172676 @default.
• W1968373669 hasRelatedWork W1985215771 @default.
• W1968373669 hasRelatedWork W2002588245 @default.
• W1968373669 hasRelatedWork W2033189766 @default.
• W1968373669 hasRelatedWork W2038553105 @default.
• W1968373669 hasRelatedWork W2039288810 @default.
• W1968373669 hasRelatedWork W2126309436 @default.
• W1968373669 hasRelatedWork W2430932435 @default.
• W1968373669 hasVolume "192" @default.
• W1968373669 isParatext "false" @default.
• W1968373669 isRetracted "false" @default.
• W1968373669 magId "1968373669" @default.
• W1968373669 workType "article" @default.